These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10854724)

  • 21. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
    Pabreza LA; Dhawan S; Kellar KJ
    Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors.
    Wang HY; Lee DH; Davis CB; Shank RP
    J Neurochem; 2000 Sep; 75(3):1155-61. PubMed ID: 10936198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity.
    Kihara T; Shimohama S; Urushitani M; Sawada H; Kimura J; Kume T; Maeda T; Akaike A
    Brain Res; 1998 May; 792(2):331-4. PubMed ID: 9593977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.
    Freedman R; Hall M; Adler LE; Leonard S
    Biol Psychiatry; 1995 Jul; 38(1):22-33. PubMed ID: 7548469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of [3H]cytisine binding to human brain membrane preparations.
    Hall M; Zerbe L; Leonard S; Freedman R
    Brain Res; 1993 Jan; 600(1):127-33. PubMed ID: 8422580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
    Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum.
    Grady SR; Meinerz NM; Cao J; Reynolds AM; Picciotto MR; Changeux JP; McIntosh JM; Marks MJ; Collins AC
    J Neurochem; 2001 Jan; 76(1):258-68. PubMed ID: 11145999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A robust homogeneous binding assay for alpha4beta2 nicotinic acetylcholine receptor.
    Hui X; Gao J; Xie X; Suto N; Ogiku T; Wang MW
    Acta Pharmacol Sin; 2005 Oct; 26(10):1175-80. PubMed ID: 16174432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM; Dávila-García MI; Ulrich YM; Kellar KJ
    J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
    Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes.
    Azam L; McIntosh JM
    Mol Pharmacol; 2006 Sep; 70(3):967-76. PubMed ID: 16735605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    Abin-Carriquiry JA; Costa G; Urbanavicius J; Cassels BK; Rebolledo-Fuentes M; Wonnacott S; Dajas F
    Eur J Pharmacol; 2008 Jul; 589(1-3):80-4. PubMed ID: 18589414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial recovery of striatal nicotinic receptors in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with chronic oral nicotine.
    Bordia T; Parameswaran N; Fan H; Langston JW; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2006 Oct; 319(1):285-92. PubMed ID: 16837557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of nicotine in the neonatal quinpirole rodent model of psychosis: Neural plasticity mechanisms and nicotinic receptor changes.
    Peterson DJ; Gill WD; Dose JM; Hoover DB; Pauly JR; Cummins ED; Burgess KC; Brown RW
    Behav Brain Res; 2017 May; 325(Pt A):17-24. PubMed ID: 28235586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors.
    Kassiou M; Bottlaender M; Loc'h C; Dolle F; Musachio JL; Coulon C; Ottaviani M; Dannals RF; Maziere B
    Synapse; 2002 Aug; 45(2):95-104. PubMed ID: 12112402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
    J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.